Skip to main content
Premium Trial:

Request an Annual Quote

Clarifi: Richard Schilsky

Richard Schilsky, former chief medical officer and executive VP of the American Society of Clinical Oncology, has joined the managing board of Clarifi. He was also the chief of hematology/oncology within the department of medicine and deputy director of the University of Chicago Comprehensive Cancer Center. Schilsky will help guide the strategic direction at Clarifi, which provides solutions for improving cancer patients' access to precision medicine. The company also operates ClarifiSelect, a platform that interprets results from commercial sequencing tests and provides a ranked list of treatment options that have been reviewed by precision oncology experts.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.